POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 9 | / | 2018 | ||||||||
Date of issue: | 2018-02-02 | ||||||||||
Short name of the issuer | |||||||||||
KRKA | |||||||||||
Subject | |||||||||||
Acquisition of treasury shares | |||||||||||
Official market - legal basis | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
With a reference to the public notice from 28 July 2017, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 26 January 2018 up to and including 1 February 2018. Krka acquired 7,151 treasury shares in the total value of EUR 421,596 on the Ljubljana Stock Exchange as follows: - on 26 January 2018: 2,732 shares at a weighted average price of EUR 59.12, - on 30 January 2018: 2,254 shares at a weighted average price of EUR 58.80, - on 31 January 2018: 453 shares at a weighted average price of EUR 58.80 and - on 1 February 2018: 1,712 shares at a weighted average price of EUR 58.94. SKB d.d. and NLB d.d. were brokers in these transactions. The total number of treasury shares prior to these transactions was 738,733 representing 2.253% of all shares issued. The total number of treasury shares after these transactions is 745,884 representing 2.274% of all shares issued. | |||||||||||
Annexes | |||||||||||
File | Description |
KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
(fullname of the issuer) | |||||||||||||
KRKA | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
8501 | Nove Mesto | ||||||||||||
(post code) | (city) | ||||||||||||
Smarjeska | 6 | ||||||||||||
(street) | (number) | ||||||||||||
+386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nie dotyczy | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2018-02-02 | Jože Colarič | President of the Management Board |